Drug Name: | Medrysone (2668-66-8) |
---|---|
PubChem ID: | 91873732 |
SMILES: | C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C |
InchiKey: | GZENKSODFLBBHQ-TWMFWCMMSA-N |
Therapeutic Category: | Adrenal Cortex Hormones, Glucocorticoids, Hormones |
Molecular Weight (dalton) | : | 344.495 |
LogP | : | 3.9403 |
Ring Count | : | 0 |
Hydrogen Bond Acceptor Count | : | 3 |
Hydrogen Bond Donor Count | : | 1 |
Total Polar Surface Area | : | 54.37 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|---|---|---|
Electrolyte Imbalance | Alpha-1A adrenergic receptor (P35348) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
Menstrual Disorder | Alpha-1A adrenergic receptor (P35348) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
Oedema | Mu-Type opioid receptor (P35372) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category